Development of decorporation agents for the actinides

Radiation Protection Dosimetry

Volumn 79, Issue 1-4, 1998, Pages 433-443

  Durbin, P W ^a   Kullgren, B ^a   Xu, J ^a   Raymond, K N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIDE; AMERICIUM; CELL ADHESION MOLECULE; CHELATING AGENT; DEFEROXAMINE MESYLATE; EDETIC ACID; FERRIC ION; NEPTUNIUM; PENTETIC ACID; PENTETIC ACID DERIVATIVE; PLUTONIUM; SIDEROPHORE; URANIUM;

CHELATION THERAPY; CONFERENCE PAPER; LIGAND BINDING; METAL BINDING; NONHUMAN; RADIATION INJURY; SOFT TISSUE INJURY;

EID: 0031719935     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a032445     Document Type: Conference Paper

References (70)

1. Schubert, J. Removal of Radioelements from the Mammalian Body. Ann. Rev. Nucl. Sci. 5, 369-412 (1955).
2. Rosenthal, M. W. Radioisotope Absorption and Methods of Elimination. Factors Influencing Elimination from the Body In. Radioisotopes in the Biosphere, Eds R. S. Caldecott and L. A. Snyder, pp. 541-563 (Minnesota Center for Continuing Study. Minneapolis, MN) (1960).
3. Catsch, A. Radioactive Metal Mobilization in Medicine (Springfield, IL: Charles C. Thomas) (1964).
4. Smith, V H. Therapeutic Removal of Internally Deposited Transuranium Elements. Health Phys. 22. 765-778 (1972)
5. Volf, V. Treatment of Incorporated Transuranium Elements. STI/DOC/10/184 (Vienna: IAEA) (1978).
6. Raymond, K. N. and Smith, W. L. Actinide-Sequestering Agents and Decontamination Applications. In: Structure and Bonding Ed. J. B Goodenough. Vol. 43, pp. 159-185 (Berlin. Springer-Verlag) (1981).
7. Duffield, J. R. and Taylor, D. M. The Biochemistry of the Actinides. In: Handbook on the Physics and Chemistry of the Actinides. Eds A. J. Freeman and C. Keller pp. 129-157 (Amsterdam: Elsevier Science) (1986).
8. Stradling, G. N. Recent Progress in Decorporation of Plutonium, Americium, and Thorium. Radiat. Prot. Dosim. 53, 297-304 (1994).
9. European Late Effects Project Group. EULEP Newsletter No. 40. Ed. J. R. Maisin (Mol, Belgium: CEN/SCK) (1985).
10. Bruenger, F. W., Taylor, D M., Taylor, G. N. and Lloyd, R. D Effectiveness of DTPA Treatments Following the Injection of Particulate Plutonium. Int. J. Radiat. Biol. 60, 803-818 (1991).
11. Breitenstein Jr, B. D. and Palmer, H E. Lifetime Follow-up of the 1976 Americium Accident Victim. Radiat. Prot. Dosim. 26. 317-322 (1989).
12. Dagirmanjian, R. Maynard, E. A. and Hodge, H. C. The Effects of Calcium Disodium Ethylenediaminetetraacetate on Uranium Poisoning in Rats J Pharmacol. Exp. Ther. 117, 20-28 (1956)
13. Catsch, A. Die Wirkung einiger Chelatbildner auf die akute Toxicität von Uranylnitrate. Klin. Wochschr. 37, 657-660 (in German) (1959).
14. Lusky, L. M. and Braun, H. A. Sodium Catechol Disulphonate Protection in Experimental Uranium Nitrate Poisoning. Fed. Proc. 9, 297, abstract (1950).
15. Smith, V. H. Prevention of Plutonium and Neptunium Deposition. In Hanford Biology Research Annual Report for 1962 (Hanford Laboratory. Richland. WA) HW-76000, pp. 143-148 (1963).
16. International Commission on Radiological Protection. Limits for Intakes of Radionuclides by Workers. ICRP 30, Part 1. Ann. ICRP 2 (3-4) (1979)
17. 241Am in Beagles by DTPA. Radiat. Res. 62, 97-106 (1975).
18. Guilmette, R. A., Lindhorst, P S and Hanlon, L. L Interaction of Pu and Am with Bone Mineral In Vitro. Radiat. Prot. Dosim. 79(1-4), 453-458 (This issue) (1998).
19. 239Pu in Bone: The Influence of Bone Remodelling. Health Phys. 21, 31-39 (1971).
20. 241Am in the Rat Femur as Influenced by DTPA Treatment. Radiat. Res. 67, 128-141 (1976).
21. Rosenthal, M. W. and Lindenbaum, A. Osteosarcoma as Related to Tissue Distribution of Monomeric and Polymeric Plutonium in Mice. In: Delayed Effects of Bone-seeking Radionuclides. Eds C W Mays et al, pp. 371-386 (University of Utah Press, Salt Lake City. UT) (1969)
22. 219Pu by Chelation Therapy. Radiat Res. 107, 296-306 (1986).
23. 241Am Removal by DTPA vs. Occurrence of Skeletal Malignancy. Health Phys. (submitted).
24. Volf, V., Polig, E. and Gemenetzis, E. Prevention of Late Effects by Removal of Radionuclides from the Body. In. Biological Implications of Radionuclides Released from Nuclear Industries, Vol. II. (Vienna: IAEA) STI/PUB/522, pp. 41-51 (1979).
25. Ballou, J. E., Dagle, G. E., McDonald, K. E. and Buschbom, R. L. Influence of Inhaled Ca-DTPA on the Long-term Effects of Inhaled Pu Nitrate. Health Phys. 32, 479-487 (1977).
26. 239Pu Labelled with Ca or ZnDTPA. Med. Radiol 24, 66-71 (in Russian) (1979).
27. Stather, J W., Stradling, G N., Gray, S. A., Moody, J. and Hodgson, A. Use of DTPA for Increasing the Rate of Elimination of Plutonium-238 and Americium-241 from Rodents After their Inhalation as the Nitrates. Human Toxicol. 4, 573-582 (1985).
28. Guilmette, R. A. and Muggenburg, B. A. Reducting the Radiation Dose from Inhaled-Americinm-241 Using Continuously Administered DTPA Therapy Int. J. Radiat. Biol. 53, 261-271 (1988).
29. Sillen, L. G. and Martell, A. E Stability Constants of Metal-Ion Complexes. Special Publication No. 17 (Chemical Society of London) (1964).
30. Scott, K. G., Crowley, J. and Foreman, H. Tracer Studies - The Metabolism of the Fission Products. Medical and Health Divisions Quarterly Report (University of California Radiation Laboratory, Berkeley, CA) UCRL-587, pp. 8-21 (1950).
31. Foreman, H. and Hamilton, J. G. The Use of Chelating Agents for Accelerating Excretion of Radionuclides. (University of California Radiation Laboratory, Berkeley, CA) UCRL-1351 (1951).
32. Hamilton, J G. and Scott, K. G Effect of Calcium Sclt of Versene upon Metabolism of Plutonium in the Rat. Proc. Soc. Exptl Biol Med. 83, 301-305 (1953).
33. Kroll, H., Korman, S., Siegel, E , Hart, H E , Rosoff, B., Spencer, H. and Laszlo, D. Excretion of Yurium and Lanthanum Chelates of Cyclohexane 1,2-Transdiamine Tetraacetic Acid and Diethylenetriaminepentaacetic Acid in Men. Nature (London) 180, 919-920 (1957)
34. Catsch, A. and Lê, D.K. Untersuchungen uber therapeutische Möglichkeiten bei Vergiftungen mil radioaktiven Spaltprodukten. 1. Mitteilung: Der Einfluss von Chelatbilnern auf das Verhalten von Radiocer im Säugetierorganismus. Strahlentherapie 104, 494-506 (in German) (1957).
35. Smith, V. H. Removal of Internally Deposited Plutonium. Nature (London) 181, 1792-1793 (1958).
36. Volf, V. Optimisation and Status of Chelation Therapy. Radiat. Prot. Dosim. 26, 331-335 (1989).
37. 3CaDTP when Given by Protracted Administration. Health Phys. 27, 285-288 (1974).
38. 238Pu(IV) from Mice by Polycatecholate, -hydroxamate or -hydroxypyridinonate Ligands. Radiat. Prot. Dosim. 26, 351-358 (1989).
39. Rosenthal, M. W., Rahman, Y. E., Moretti, E. A. and Cerny, E A. Removal of Polymeric Plutonium by DTPA Directed into Cells by Liposome Encapsulation. Radiat. Res 63, 262-274 (1975).
40. 2 from the Hamster by Inhalation of Chelating Agents. Health Phys. 42, 520-525 (1982).
41. Miller, S. C , Bruenger, F. W., Kuswik-Rabiega, G., Liu, G. and Lloyd, R. D. Duration and Dose-Related Effects of an Orally Administered Partially Lipophilic Polyaminocarboxylic Acid on the Decorporation of Plutinium and Americtum. J. Pharmacol. Exp. Ther. 267, 548-554 (1993).
42. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. New Agents for in vivo Chelation of Uranium(VI): Efficacy and Toxicity in Mice of Multidentate Catecholate and Hydroxypyridinonate Ligands. Health Phys. 72, 865-879 (1997).
43. 237Neptunium: Oxidation State in vivo and Chelation by Multidentate Catecholate and Hydroxypyridinonate Ligands. Health Phys. 75, 34-50 (1998).
44. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. In vivo Chelation of Am(III), Pu(IV), Np(V) and U(VI) in Mice by TREN-(Me-3.2-HOPO). Radiat. Prot. Dosim. 53, 30-309 (1994).
45. Taylor D. M. The Effects of Desferrioxamine on the Retention of Actinide Elements in the Rat. Health Phys. 13, 135-140 (1967).
46. Rodgers, S. J. and Raymond, K. N. Synthesis and Kinetics of Iron Removal from Transferrin of Catechoyl Derivatives of Desferrioxamine B J. Med. Chem. 26, 439-442 (1983).
47. Volf, V., Seidel, A. and Takada, K. Comparative Effectiveness of Ca-DTPA. Desferrioxamine B and their Combination in Removing Transuranium Elements from Rats. Health Phys. 32, 155-157 (1977).
48. 238Pu(IV) from Mice by Sulfonated Tetrameric Catechoyl Amides. Radiat. Res. 81, 170-187 (1980).
49. 238Pu Elimination from Mice by Poly(catechoylamide) Ligands. Radiat. Res. 99, 85-105 (1984).
50. Durbin, P. W., Kullgren, B., Jeung, N., Xu, J., Rodgers, S. J. and Raymond, K. N. Octadentate Catecholamide Ligands for Pu(IV) Based on Linear or Preorganized Molecular Backbones. Human Exp. Toxicol. 15, 352-360 (1996).
51. 238Pu(IV) in vivo by 3,4,3-LICAM(C): Effects of Ligand Methylation and pH. Health Phys. 56, 839-855 (1989).
52. Riley, P. E., Abu-Dari, K. and Raymond, K. N. Synthesis of Metal Complexes of 1-Hydroxy-2-pyridinone and the Crystal Structure of Tetrakis (1-oxy-2-pyridonato)aquothorium(IV) Dihydrate. Inorg. Chem. 22, 3940-3944 (1983).
53. Kappel, M. J., Nitsche, H. and Raymond, K. N. Complexation of Plutonium and Americium by Catecholate Ligands. Inorg. Chem. 24, 605-611 (1985).
54. Scarrow, R. C., Riley, P. E., Abu-Dan, K., White, D. L. and Raymond, K. N. Synthesis, Structures, and Thermodynamics of Complexation of Cobalt(III) and Iron(III) Tris Complexes of Several Chelating Hydroxvpvridinones. Inorg. Chem. 24, 954-967 (1985).
55. White, D. L., Durbin, P. W., Jeung, N. and Raymond, K. N. Synthesis and Initial Biological Testing of Polydentate Oxohydroxypyridinecarboxylate Ligands. J. Med. Chem. 31, 11-18 (1988).
56. Sofen, S. R., Abu-Dari, K , Freyberg, D. P. and Raymond, K. N. A Ligand Field Effect in the Crystal and Molecular Structures of Tetrakis(catecholato)uranate(IV) and -thorate(IV). J. Am. Chem. Soc. 100, 7882-7887 (1978).
57. Smith, W. L. and Raymond, K. N. Synthetic and Structural Chemistry of Tetrakis (N-alkylalkanehydroxamato)thorium(IV) Complexes, J. Am. Chem. Soc 103, 3341-3349 (1981).
58. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W. Chelation Therapy by DFO-HOPO and 3,4,3-LIHOPO for Injected Pu-238 and Am-241 in the Rat. Effect of Dosage, Time and Mode of Chelate Administration. Int. J. Radiat. Biol. 70, 765-772 (1996).
59. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W. Treatment with 3,4,3-LIHOPO of Simulated Wounds Contaminated with Plutonium and Americium in the Rat. Int. J Radiat. Biol. 70, 109-114 (1996).
60. Paquet, F., Poney, J.-L., Métivier, H., Grillon, G , Fritsch, P., Burgada, R., Bailly, T , Raymond, K. N. and Durbin, P. W. Efficacy of 3,4,3-LI(1,2-HOPO) for Enhancing the Excretion of Plutonium from Rat after Simulated Wound Contamination as a Tributyl-n-phosphate Complex. Int J. Radiat Biol. 68, 663-668 (1995).
61. Stradling, G. N., Gray, S. A., Pearce, M. J., Wilson, I., Moody, J. C., Burgada, R., Durbin, P. W. and Raymond, K. N. Decorporation of Thorium-228 from the Rat by 3,4,3-LIHOPO and DTPA after Simulated Wound Contamination. Human Toxicol. 14, 165-169 (1995)
62. Fritsch, P., Herbreteau, D., Moutairou, K., Lantenois, G., Richard-Le Naour, H., Grillon, G., Hoffschir, D., Poney, J. L., Laurent, A. and Masse, R. Comparative Toxicity of 3,4,3-LIHOPO and DTPA in Baboons. Radiat. Prot. Dosim. 53, 315-318 (1994).
63. Uhlir, L. C., Durbin, P. W., Jeung, N. and Raymond, K. N. Synthesis and Initial Biological Testing of Octadentate Mixed Catecholate-Hydroxypyridinonate Ligands. J. Med. Chem. 36, 504-509 (1993).
64. Xu, J., Durbin, P. W., Kullgren, B. and Raymond, K. N. Synthesis and Initial Biological Evaluation of Multidentate 4-Carbamoyl-3-hydroxy-1-methyl-2(IH)-pyridinone Ligands for in vivo Plutonium(IV) Chelation. J. Med. Chem. 38, 2606-2614 (1995).
65. 98Mo. II. Synthesis and Characterization of Actinide-Specific Chelating Agents. Thesis, University of California, Berkeley, CA (1996).
66. Stradling, G. N., Gray, S. A., Pearce, M. J., Wilson, I., Moody, J. C., Hodgson, A. and Raymond, K. N. Efficacy of TREN-(Me-3,2-HOPO), 5-LI(Me-3,2-HOPO) and DTPA for Removing Plutonium and Americium from the Rat after Inhalation and Wound Contamination as Nitrates: Comparison with 3,4,3-LI(1,2-HOPO). (National Radiological Protection Board, Chilton UK) NRPB-M534 (1995).
67. Volf, V. and Wirth, R. Effective Chelation Therapy after Incorporation of Neptunium-239 in Rats. Int. J. Radiat. Biol. 50, 955-959 (1986).
68. Paquet, F., Métivier, H., Poncy, J. L. and Burgada, R. Evaluation of the Efficiency of DTPA and other New Agents for Removing Neptunium from Target Organs. Int. J. Radiat. Biol. 71, 613-621 (1997).
69. Stradling, G. N., Gray, S. A., Moody, J. C. and Ellender, M. The Efficacy of Tiron for Enhancing the Excretion of Uranium from the Rat. Human Exp. Toxicol. 10. 195-198 (1991).
70. Henge-Napoli, M. H., Archimbaud, M., Ansoborlo, E., Métivier, H. and Gourmelon, P. Efficacy of 3,4,3-LIHOPO for Reducing the Retention of Uranium in Rat after Acute Administration. Int. J. Radiat, Biol. 68, 389-393 (1995).